A Danish register study of 132,585 adults with new type 2 diabetes found that those who started a statin within a year of diagnosis had a 15% lower relative risk of dementia over 10 years than those who did not start one.[1] The absolute difference was small, and the study was observational, so it is a reason to have a conversation with your clinician, not a reason to start a drug on your own.
What the researchers did
The team used Danish national registers to find 132,585 people who had never taken a statin and who developed type 2 diabetes between 2006 and 2019. They followed them until the end of 2021 and tracked diagnoses of dementia from any cause. People were sorted by when they started a statin: within one year of diagnosis (early), between one and five years (late), or not within five years (the reference group).[1]
Observational data can be skewed by who gets treated and when. To reduce that, the authors used a method (clone-censor-weighting) designed to imitate a randomized controlled trial using existing records.[1] It helps, but it does not turn registry data into a trial.
What they found
- Over a median 7.1 years of follow-up, 3,592 people (2.7%) were diagnosed with dementia.[1]
- Estimated 10-year dementia risk was 3.9% with no statin, 3.5% with a late start and 3.3% with an early start.[1]
- That works out to a 15% lower relative risk for early starters (95% confidence interval 9% to 21%) and a 10% lower relative risk for late starters (3% to 15%).[1]
- In absolute terms, that is 0.59 percentage points lower for early starters and 0.38 points lower for late starters.[1]
What this study does not show
- It does not show that statins prevent dementia. The authors say trial evidence is needed to confirm the finding.[1]
- It covers people with type 2 diabetes in Denmark who had not taken statins before. It says nothing about people without diabetes.
- A relative drop of 15% sounds large, but it comes from a risk that starts under 4% over 10 years. The absolute gap was about half a percentage point.
What to do with it
- If you have type 2 diabetes, ask your clinician what your LDL cholesterol is and whether a statin makes sense for you. The study picked out LDL cholesterol as a modifiable risk factor for dementia.[1]
- Bring up timing. In this study the people who started soonest had the lowest estimated risk, so it is worth asking whether timing matters for you.
- Do not start, stop or change a statin or any other medication on your own. Dose, side effects and other drugs you take all matter.
- Keep the habits that move the same numbers: regular activity, sleep, blood sugar and blood pressure checks.
References
[1] Ternhamar T, Johansen MØ, Nordestgaard BG, Afzal S. Association between timing of statin treatment after diabetes diagnosis and risk of dementia: a nationwide observational study. The Lancet Regional Health – Europe, 2026;69:101814. Population: 132,585 statin-naive Danish adults diagnosed with type 2 diabetes 2006-2019, followed to 31 December 2021 (median 7.1 years). DOI: https://doi.org/10.1016/j.lanepe.2026.101814. Finding as used: 3,592 (2.7%) developed dementia; estimated 10-year absolute dementia risk 3.9% with no statin, 3.3% with early initiation (within 1 year) and 3.5% with late initiation (1-5 years); early initiation associated with 15% lower relative risk (95% CI 9%-21%) and late with 10% lower (3%-15%); absolute risk differences 0.59% and 0.38%; LDL cholesterol named as a modifiable dementia risk factor; the authors state trial evidence is needed. ↑︎
Kurt Greiner
Kurt is a digital strategist and IT professional blending emerging technology with practical application to help businesses and individuals streamline their digital presence. His current work focuses on the intersection of intentional living and technological resilience, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.
Leave a Reply